Isomorphic Labs
Private
AI Drug Discovery
Founded 2021London, UKNot publicly disclosed employees
About Isomorphic Labs
Isomorphic Labs is an Alphabet AI drug-discovery company spun out of Google DeepMind in 2021 and led by Demis Hassabis. It builds on AlphaFold-lineage research to design drug candidates with its AI drug design engine (IsoDDE). In May 2026 it raised a $2.1B Series B led by Thrive Capital.
Products & Services
3- IsoDDE (AI drug design engine)
- Internal drug pipeline
- Pharma research partnerships
People & ecosystem
Key People
- Demis Hassabis (Founder & CEO)
Competitive Landscape
- Recursion
- Xaira Therapeutics